دورية أكاديمية

Phase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer

التفاصيل البيبلوغرافية
العنوان: Phase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer
المؤلفون: Lück, Hans-Joachim, Lübbe, Kristina, Reinisch, Mattea, Maass, Nicolai, Feisel-Schwickardi, Gabriele, Tomé, Oliver, Janni, Wolfgang, Aydogdu, Mustafa, Neunhöffer, Tanja, Ober, Angelika, Aktas, Bahriye, Park-Simon, Tjoung-Won, Schumacher, Claudia, Höffkes, Heinz-Gert, Illmer, Thomas, Wagner, Harald, Mehta, Keyur, von Minckwitz, Gunter, Nekljudova, Valentina, Loibl, Sibylle
المصدر: Breast Cancer Research and Treatment. January 2015 149(1):141-149
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:01676806
15737217
DOI:10.1007/s10549-014-3217-y